HCPLive

MARCH 20, 2024

An expert in dermatologic conditions examines laboratory requirements for initiating deucravacitinib in patients with moderate-to-severe plaque psoriasis and the impact of deucravacitinib on the treatment landscape.

Plaque 52

Plaque Laboratory 52

Frontiers in Cardiovascular Medicine

JULY 5, 2024

Coronary artery disease is caused by the buildup of atherosclerotic plaque in the coronary arteries, affecting the blood supply to the heart, one of the leading causes of death around the world. This paper explores the challenges and future directions associated with applying patient-specific in silico models in catheterisation laboratories.

Laboratory 52

Laboratory Coronary Artery Disease Interventional Cardiology Plaque 52

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Clinical and laboratory safety evaluations were made at baseline and every 3 weeks until the end of the study.

Coronary Artery Disease 59

Coronary Artery Disease Laboratory Plaque Biomarkers 59

All About Cardiovascular System and Disorders

MARCH 7, 2024

Detailed analysis of the excised carotid plaques were carried out with pyrolysis-gas chromatography-mass spectrometry, stable isotope analysis, and electron microscopy. Primary endpoint of the study was a composite of myocardial infarction, stroke, or death from any cause in those who had micro and nanoplastics in the carotid plaque.

Plaque 52

Plaque Myocardial Infarction Laboratory Cardiac Function 52

Circulation

JANUARY 15, 2024

Nevertheless, the relationship between CAC and the susceptibility of a plaque to provoke a thrombotic event remains incompletely understood. This review summarizes the current understanding and literature on CAC.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

All About Cardiovascular System and Disorders

APRIL 17, 2024

Conventional coronary angiograms are obtained by injecting medications directly into the coronary arteries and imaging them with X-ray equipment in cardiac catheterization laboratory. But it may not be that useful just to screen for blocks or build-up of plaques in those without any symptoms.

Coronary Angiogram 40

Coronary Angiogram Catheterization Laboratory Angioplasty Chest Pain 40

Circulation

NOVEMBER 11, 2024

Introduction/Background:According to the American Heart Association, the accumulation of plaque in the walls of arteries is identified as the primary cause of atherosclerotic cardiovascular disease (ASCVD). Circulation, Volume 150, Issue Suppl_1 , Page A4146638-A4146638, November 12, 2024.

Biomarkers 40

Biomarkers Cardiovascular Disease Laboratory Plaque 40